medigraphic.com
ISSN 1405-1710 (Print)

2014, Number 2

<< Back Next >>

Rev Cent Dermatol Pascua 2014; 23 (2)

Coronary risk in androgenetic alopecia

Espinoza TM, Morales M, Peralta PML, Jurado SF

Language: Spanish
References: 15
Page: 50-54
PDF size: 167.16 Kb.


ABSTRACT

Introduction: Androgenetic alopecia (AGA) is a time-evolving process, characterized by miniaturization of androgen sensitive hair follicles in the scalp. Previous studies indicate that the AGA is associated with increased risk of coronary disease. Objective: Determine the magnitude of the association between AGA pattern in the vertex of Hamilton-Norwood and coronary risk by measuring serum lipids. Material and methods: At the Dermatology Center «Dr. Ladislao de la Pascua» a comparative cross-sectional study was made in men 20 to 47 years old, with and without androgenetic alopecia in vertex. Patients with other risk factors for coronary heart disease were excluded. Levels of total cholesterol, HDL and triglycerides were measured by blood sampling. Results: 34 patients with androgenetic alopecia and 36 controls were recruited. The average age was 38 (SD 7.74 years) and 37 (SD 7.46 years) years respectively. The levels of total cholesterol (201.21 versus 204.17 mg/dL), LDL (128.92 versus 127.53 mg/dL), HDL (37.46 versus 42.64 mg/dL) and triglycerides (173.7 versus 177.78 mg/dL) were similar in patients with and without androgenetic alopecia. Conclusion: There is no difference in lipid levels between men with and without androgenetic alopecia. Although it has been shown that patients with androgenetic alopecia have increased risk of heart disease, it does not depend exclusively on the levels of cholesterol and triglycerides.


REFERENCES

  1. Yeo IK, Jang WS, Min PK, Cho HR, Cho SW, Hong NS et al. An epidemiological study of androgenic alopecia in 3,114 Korean patients. Clin Exp Dermatol. 2014; 39: 25-29.

  2. Cooke NT. Male pattern alopecia and coronary artery disease in men. Br J Dermatol. 1979; 101: 455-458.

  3. Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA. 1993; 269: 998-1003.

  4. Shahar E, Heiss G, Rosamond WD, Szklo M. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol. 2008; 167: 676-683.

  5. Herrera CR, D’Agostino RB, Gerstman BB, Bosco LA, Belanger AJ. Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol. 1995; 142(8): 828-833.

  6. Ellis JA, Stebbing M, Harrap SB. Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clin Sci (Lond). 2001; 100: 401-404.

  7. González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J et al. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol. 2009; 71: 494-499.

  8. Berry JD, Dyer A, Cai X, GarsideDB, Ning H, Thomas A, Greenland P, van Horn L, Tracy RP, Lloyd-Jones DM. Lifetime risks of cardiovascular disease. N Engl J Med. 2012; 366: 321-329.

  9. Sadighha A, Zahed GM. Evaluation of lipid levels in androgenetic alopecia in comparison with control group. J Eur Acad Dermatol Venereol. 2009; 23: 80-81.

  10. Arias-Santiago S, Gutiérrez-Salmerón MT, Buendía-Eisman A, Girón-Prieto MS, Naranjo-Sintes R. A comparative study of dyslipidaemia in Men and Women with Androgenic Alopecia. Acta Derma Venereol. 2010; 90: 485-487.

  11. Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Alopecia androgénica masculina y factores de riesgo cardiovascular: estudio de casos y controles. Actas Dermosifiliogr. 2010; 101: 248-256.

  12. Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet. 2000; 356: 1165-1166.

  13. Rojas R, Aguilar-Salinas CA, Jiménez-Corona A et al. Metabolic syndrome in Mexican adults. Results from the National Health and Nutrition Survey 2006. Salud Pública Mex. 2010; 52(Suppl. 1): S11-S18.

  14. Giltay EJ, Toorians AWFT, Sarabdjitsingh AR, de Vries NA, Gooren LJ. Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transexuals. J Endocrin. 2004; 180: 107-112.

  15. Yamada T, Hara K, Umematsu H, Kadowaki T. Male pattern baldness and its association with coronary heart disease: a meta-analysis. BMJ Open. 2013; 3: e002537.




2020     |     www.medigraphic.com